Mikkel E. Sørensen

Thinner cortex is associated with psychosis onset in individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group mega-analysis

Kristen M. Haut, O. Andreassen, M. Kaess, 2021, medRxiv.

Add-On MEmaNtine to Dopamine Antagonism to Improve Negative Symptoms at First Psychosis- the AMEND Trial Protocol

C. Pantelis, A. Lahti, H. Siebner, 2022, Frontiers in Psychiatry.

Cortico-cognition coupling in treatment resistant schizophrenia

E. Rostrup, C. Pantelis, E. Skafidas, 2022, NeuroImage: Clinical.

Cortico-cognition coupling in treatment resistant schizophrenia

E. Rostrup, C. Pantelis, E. Skafidas, 2022, NeuroImage: Clinical.

Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis

Kristen M. Haut, O. Andreassen, M. Kaess, 2022, Translational Psychiatry.

Lower Vitamin C Levels Are Associated With Less Improvement in Negative Symptoms in Initially Antipsychotic-Naïve Patients With First-Episode Psychosis

Martin W. Skjerbæk, B. Glenthøj, J. Lykkesfeldt, 2022, The international journal of neuropsychopharmacology.

Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.

Kristen M. Haut, O. Andreassen, M. Kaess, 2021, JAMA psychiatry.

The metabolic adverse effects of antipsychotic use in individuals with intellectual and/or developmental disability: A systematic review and meta‐analysis

G. Remington, P. Desarkar, Y. Lunsky, 2022, Acta psychiatrica Scandinavica.

Prediction of Early Symptom Remission in Two Independent Samples of First-Episode Psychosis Patients Using Machine Learning.

N. Koutsouleris, C. Pantelis, B. Glenthøj, 2021, Schizophrenia bulletin.